Flores, Eduardo P.

HRN: 21-52-67  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
CEFTRIAXONE 1G (VIAL)
07/06/2022
07/15/2022
IVT
2g
OD
Fungating Mass R Gluteal Area With Multiple Fistula
Waiting Final Action 
07/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/06/2022
07/14/2022
IVT
500mg
Q8
Fungating Mass R Gluteal Area With Multiple Fistula
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: